Literature DB >> 35644529

Transcriptional Regulation of Solute Carrier (SLC) Drug Transporters.

Shiwei Zhou1, Yan Shu2.   

Abstract

Facilitated transport is necessitated for large size, charged, and/or hydrophilic drugs to move across the membrane. The drug transporters in the solute carrier (SLC) superfamily, mainly including organic anion-transporting polypeptides (OATPs), organic anion transporters (OATs), organic cation transporters (OCTs), organic cation/carnitine transporters (OCTNs), peptide transporters (PEPTs), and multidrug and toxin extrusion proteins (MATEs), are critical facilitators of drug transport and distribution in human body. The expression of these SLC drug transporters is found in tissues throughout the body, with high abundance in the epithelial cells of major organs for drug disposition, such as intestine, liver, and kidney. These SLC drug transporters are clinically important in drug absorption, metabolism, distribution, and excretion. The mechanisms underlying their regulation have been revealing in recent years. Epigenetic and nuclear receptor-mediated transcriptional regulation of SLC drug transporters have particularly attracted much attention. This review focuses on the transcriptional regulation of major SLC drug transporter genes. Revealing the mechanisms underlying the transcription of those critical drug transporters will help us understand pharmacokinetics and pharmacodynamics, ultimately improving drug therapeutic effectiveness while minimizing drug toxicity. Significance Statement It has become increasingly recognized that solute carrier (SLC) drug transporters play a crucial, and sometimes determinative, role in drug disposition and response, which is reflected in decision-making during not only clinical drug therapy but also drug development. Understanding the mechanisms accounting for the transcription of these transporters is critical to interpret their abundance in various tissues under different conditions, which is necessary to clarify the pharmacological response, adverse effects, and drug-drug interactions for clinically used drugs.
Copyright © 2020 American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Keywords:  Organic cation transport; Regulation - transcriptional; drug disposition; drug transport; organic anion transport

Year:  2022        PMID: 35644529      PMCID: PMC9488976          DOI: 10.1124/dmd.121.000704

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.579


  188 in total

1.  Circadian regulation of transporter expression and implications for drug disposition.

Authors:  Jiří Pácha; Kateřina Balounová; Matúš Soták
Journal:  Expert Opin Drug Metab Toxicol       Date:  2021-01-04       Impact factor: 4.481

Review 2.  Pregnane X receptor and drug-induced liver injury.

Authors:  Yue-Ming Wang; Sergio C Chai; Christopher T Brewer; Taosheng Chen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2014-09-25       Impact factor: 4.481

3.  Transcriptional regulation of human organic anion transporter 1 by B-cell CLL/lymphoma 6.

Authors:  Waja Wegner; Gerhard Burckhardt; Maja Henjakovic
Journal:  Am J Physiol Renal Physiol       Date:  2014-09-18

4.  Effect of methotrexate treatment on expression levels of multidrug resistance protein 2, breast cancer resistance protein and organic anion transporters Oat1, Oat2 and Oat3 in rats.

Authors:  Yoshihiko Shibayama; Kazami Ushinohama; Ryuji Ikeda; Yoshimi Yoshikawa; Toshiro Motoya; Yasuo Takeda; Katsushi Yamada
Journal:  Cancer Sci       Date:  2006-08-22       Impact factor: 6.716

5.  Regulation of mouse organic anion-transporting polypeptides (Oatps) in liver by prototypical microsomal enzyme inducers that activate distinct transcription factor pathways.

Authors:  Xingguo Cheng; Jonathan Maher; Matthew Z Dieter; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2005-05-26       Impact factor: 3.922

6.  Carnitine synthesis and uptake into cells are stimulated by fasting in pigs as a model of nonproliferating species.

Authors:  Robert Ringseis; Nicole Wege; Gaiping Wen; Christine Rauer; Frank Hirche; Holger Kluge; Klaus Eder
Journal:  J Nutr Biochem       Date:  2008-10-15       Impact factor: 6.048

7.  PPARalpha agonists positively and negatively regulate the expression of several nutrient/drug transporters in mouse small intestine.

Authors:  Toshitake Hirai; Yuka Fukui; Kiyoto Motojima
Journal:  Biol Pharm Bull       Date:  2007-11       Impact factor: 2.233

Review 8.  The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteinsIntroduction.

Authors:  Matthias A Hediger; Michael F Romero; Ji-Bin Peng; Andreas Rolfs; Hitomi Takanaga; Elspeth A Bruford
Journal:  Pflugers Arch       Date:  2003-11-18       Impact factor: 3.657

Review 9.  Hepatic OATP1B transporters and nuclear receptors PXR and CAR: interplay, regulation of drug disposition genes, and single nucleotide polymorphisms.

Authors:  Henriette E Meyer zu Schwabedissen; Richard B Kim
Journal:  Mol Pharm       Date:  2009 Nov-Dec       Impact factor: 4.939

Review 10.  Transcriptional regulation of hepatic lipogenesis.

Authors:  Yuhui Wang; Jose Viscarra; Sun-Joong Kim; Hei Sook Sul
Journal:  Nat Rev Mol Cell Biol       Date:  2015-11       Impact factor: 94.444

View more
  1 in total

Review 1.  Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers.

Authors:  Vladimir Khavinson; Natalia Linkova; Ekaterina Kozhevnikova; Anastasiia Dyatlova; Mikhael Petukhov
Journal:  Int J Mol Sci       Date:  2022-07-13       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.